GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » ROIC %

Optimind Pharma (XCNQ:OMND) ROIC % : -20.51% (As of Nov. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Optimind Pharma's annualized return on invested capital (ROIC %) for the quarter that ended in Nov. 2024 was -20.51%.

As of today (2025-03-30), Optimind Pharma's WACC % is 8.23%. Optimind Pharma's ROIC % is -86.05% (calculated using TTM income statement data). Optimind Pharma earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Optimind Pharma ROIC % Historical Data

The historical data trend for Optimind Pharma's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma ROIC % Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23 Feb24
ROIC %
- -64.39 -109.34

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.45 -80.15 -223.36 -189.17 -20.51

Competitive Comparison of Optimind Pharma's ROIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Optimind Pharma's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optimind Pharma's ROIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimind Pharma's ROIC % distribution charts can be found below:

* The bar in red indicates where Optimind Pharma's ROIC % falls into.


;
;

Optimind Pharma ROIC % Calculation

Optimind Pharma's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Feb. 2024 is calculated as:

ROIC % (A: Feb. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Feb. 2023 ) + Invested Capital (A: Feb. 2024 ))/ count )
=-0.767 * ( 1 - 0.64% )/( (1.219 + 0.175)/ 2 )
=-0.7620912/0.697
=-109.34 %

where

Optimind Pharma's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Nov. 2024 is calculated as:

ROIC % (Q: Nov. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Aug. 2024 ) + Invested Capital (Q: Nov. 2024 ))/ count )
=-0.036 * ( 1 - 0% )/( (0.175 + 0.176)/ 2 )
=-0.036/0.1755
=-20.51 %

where

Note: The Operating Income data used here is four times the quarterly (Nov. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optimind Pharma  (XCNQ:OMND) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Optimind Pharma's WACC % is 8.23%. Optimind Pharma's ROIC % is -86.05% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Optimind Pharma ROIC % Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimind Pharma Business Description

Traded in Other Exchanges
N/A
Address
77 King Street West, Suite 3000, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Optimind Pharma Headlines

No Headlines